24 results
8-K
EX-99.1
e4uapc9li65hn1 l1bq
12 May 22
ENDRA Life Sciences Reports First Quarter 2022 Financial Results and Provides Business Update
4:06pm
8-K
EX-1.1
aodi5jzl5kl
21 Jun 21
Entry into a Material Definitive Agreement
4:58pm
8-K
EX-99.1
106flaz32ng cmhgu4
17 May 21
ENDRA Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update
4:05pm
8-K
EX-99.1
4m3z9gm 7lfn33juq
25 Mar 21
ENDRA Life Sciences Reports 2020 Fourth Quarter and Full Year Financial Results, Provides Business Update
12:00am
8-K
EX-1.1
jub1553u9rpeyub 2wt3
19 Feb 21
Entry into a Material Definitive Agreement
4:13pm
8-K
EX-1.1
xdh nr1orbz
18 Dec 20
ENDRA Life Sciences Announces Proposed Public Offering of Common Stock
5:04pm
8-K
EX-1.1
vba9ofc b2
25 Sep 20
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-99.1
p5qg4
13 Apr 20
ENDRA Life Sciences Announces Cash Strategy and Business Update in Response to COVID-19
4:29pm
8-K
EX-10.1
h0s6zykmfxg5mtzu
26 Dec 19
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-10.1
93xqgq3 mer5tvdp
11 Dec 19
ENDRA Life Sciences Completes $8.1 Million Private Placement
5:14pm
8-K
EX-10.1
zlq7i 7b7t7m
29 Jul 19
ENDRA Life Sciences Completes Private Placement of $2.8 Million of Convertible Secured Notes and Warrants
8:40am